Julius J Schmidt

5PUBLICATIONS
14CO-AUTHORS
Environmental epidemiologyCardiology (incl. cardiovascular diseases)HaematologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 30, 2026
Pharmacokinetics of cefiderocol during prolonged intermittent kidney replacement therapy in two patients with septic shock.

Julius J Schmidt, Julia Hagemann, Uta Hillebrand

|Dec 07, 2021
Interim analysis of the COSA (COVID-19 patients treated with the Seraph® 100 Microbind® Affinity filter) registry.

Julius J Schmidt, Dan Nicolae Borchina, Mariet Van't Klooster

|Dec 03, 2021
Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19.

Malgorzata Wygrecka, Anna Birnhuber, Benjamin Seeliger

|Sep 29, 2021
Fosfomycin single- and multiple-dose pharmacokinetics in patients undergoing prolonged intermittent renal replacement therapy.

Lisa K V Gerecke, Julius J Schmidt, Carsten Hafer

|Jul 24, 2020
In vitro elimination of anti-infective drugs by the Seraph® 100 Microbind® affinity blood filter.

Julius J Schmidt, Gabriele Eden, Malin-Theres Seffer

Pageof 1